|
06/19/2018
|
Summary ToggleNovus Therapeutics Receives FDA Guidance at Type C Meeting for OP-02 in the Treatment and Prevention of Otitis Media
|
|
05/11/2018
|
Summary ToggleNovus Therapeutics Reports First Quarter 2018 Financial Results
|
|
04/02/2018
|
Summary ToggleNovus Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
|
|
11/21/2017
|
Summary ToggleNovus Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference
|
|
11/08/2017
|
Summary ToggleNovus Therapeutics Reports Third Quarter 2017 Results
|
|
11/06/2017
|
Summary ToggleNovus Therapeutics Announces the Promotion of Dr. Catherine Turkel to President
|
|
08/09/2017
|
Summary ToggleNovus Therapeutics Reports Second Quarter 2017 Results
|
|
07/10/2017
|
Summary ToggleNovus Therapeutics Announces Change in Management
|
|
06/12/2017
|
Summary ToggleNovus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
|
|
05/10/2017
|
Summary ToggleOtic Pharma Completes Merger with Tokai Pharmaceuticals
|
